Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Use of Saccharomyces boulardii versus Bismuth Subsalicylate in Nosocomial Diarrhea
TCTR20250904004Phase 3Completed
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Aug 2016
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of saccharomyces boulardii, bismuth subsalicylate in Nosocomial Diarrhea, sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Aug 2016; status: completed.
02
Drugs
saccharomyces boulardiibismuth subsalicylate
03
Conditions
Nosocomial Diarrhea
Beyond the preview
Go deeper on TCTR20250904004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250904004.